Stockreport

UPDATE -- Generex Biotechnology Makes Major Advance On $22 Billion Wound Care Market Announcing Milestone Agreement

GENEREX BIOTECHNOLOGY  (GNBT) 
US:NASDAQ Investor Relations: generex.com/investor
PDF Generex Biotechnology Partner Olaregen Therapeutix Inc. Signs Manufacturing Agreements for Excellagen® Wound Healing Collagen Matrix Collagen Solutions & Berkshire Ster [Read more]